Efficacy and Safety of Unloading Dose of Ticagrelor Before Delayed Percutaneous Coronary Intervention in Patients with Non-St Segment Elevation Acute Coronary Syndromes

Wu Chun,Du Yinlong,Dong Xue

DOI: https://doi.org/10.3969/j.issn.1007-5410.2018.04.004

2018-01-01

Abstract:Objective To evaluate the effectiveness and safety of ticagrelor with or without a loading starting dose before delayed percutaneous coronary intervention(PCI)in patients with non-ST segment elevation acute coronary syndrome(NSTEACS). Methods This study was a prospective, controlled study.A total of 177 NSTEACS patients who underwent delay PCI were enrolled into this study in Peking University Shenzhen Hospital from September of 2015 to October of 2016.Loading strategy of ticagrelor was made by initial diagnosed physician.Starting dose of 90 mg of ticagrelor subsequent to 90 mg twice a day was prescribed in observation group, while starting dose of 180 mg of ticagrelor subsequent to 90 mg twice a day was prescribed in control group.Optimal medication was all prescribed in two groups and delayed PCI was performed in 24-72 hours.The major adverse cardiac events(MACE)include cardiac death, myocardial infarction and stroke and safety outcome include major bleeding and mild bleeding at 12 months after PCI. Results The level of troponin T elevation at 4 hours of post-PCI and MACE after 1 year did not show significant difference between two groups(P>0.05). Bleeding incidence did not show significant difference between two groups(P>0.05). Conclusions Effectiveness and bleeding risk are similar in NSTEACS patients with or without loading dose of ticagrelor who undergo delay PCI. Key words: Ticagrelor; Unloading dose; Delayed percutaneous coronary intervention